Heart-Disease Risk Soars After COVID — Even with a Mild Case Even a mild case of COVID-19 can increase a person’s risk of cardiovascular problems for at least a year after diagnosis, a new study1 shows. Researchers found that rates of many conditions, such as heart failure and stroke, were
Long-Haul COVID Comes into Focus Thanks to St. Louis Doctor’s Research Long-haul COVID-19 has proven one of the most troubling mysteries in a virus that’s caused no shortage of bafflement. Why do some people hospitalized with the virus develop symptoms that linger for months after infection? And, perhaps more bewilderingly,
MU Study Identifies Mutations Specific to Omicron Variant While the Omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the Omicron variant’s high rate of infection. Read more...
What Makes an mRNA Vaccine So Effective Against Severe COVID-19? The first two vaccines created with mRNA vaccine technology — the Pfizer/BioNTech and Moderna COVID-19 vaccines — are arguably two of the most effective COVID vaccines developed to date. In clinical trials, both were more than 90% effective at preventing
Coronavirus Can Persist for Months After Traversing Body The coronavirus that causes Covid-19 can spread within days from the airways to the heart, brain and almost every organ system in the body, where it may persist for months, a study found. Read more...
A New COVID-19 Spit Test Is as Easy as 1-2-3 What if a COVID test was as easy as one, two, three? A team of researchers led by Jim Collins, a biomedical engineer at Harvard’s Wyss Institute for Biologically Inspired Engineering, have created a test that detects SARS-CoV-2 infection from
COVID and the Brain: Researchers Zero in on How Damage Occurs How COVID-19 damages the brain is becoming clearer. New evidence suggests that the coronavirus’s assault on the brain could be multipronged: it might attack certain brain cells directly, reduce blood flow to brain tissue or trigger production of immune
CRISPR-Based Anti-Viral Therapy Could One Day Foil the Flu—and COVID-19 CRISPR gene-editing technology has tremendous potential for making non-heritable DNA changes that can treat or even cure a wide range of devastating disorders, from HIV to muscular dystrophy Now, a recent animal study shows that another CRISPR system—targeting viral RNA
UMKC’s Health Equity Institute works to halt COVID-19 pandemic in KC Not even pounding rain can keep Rico Beuford from solving a problem. On a rainy Wednesday, the medical student at the University of Missouri-Kansas City volunteered at a drive-thru COVID-19 testing site in Kansas City, Missouri. See story...